{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:10:36Z","timestamp":1760058636215,"version":"build-2065373602"},"reference-count":15,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Background: This case report investigates the effects of sotorasib treatment in a patient with acquired von Willebrand syndrome (AVWS) associated with monoclonal gammopathy of undetermined significance (MGUS), who subsequently developed non-small-cell lung carcinoma (NSCLC) with a KRAS G12C mutation. Case Presentation: The patient, a 79-year-old male, presented with a prolonged history of recurrent lower gastrointestinal bleeding attributed to digestive angiodysplasia, which had persisted for over 30 years. AVWS was suspected based on a qualitative deficiency in von Willebrand factor (VWF), with abnormal results for factor VIII activity (FVIII:C), VWF antigen (VWF:Ag), and VWF ristocetin cofactor activity (VWF:Rco) (40%, 20%, and &lt;2.4%, respectively). Further evaluation revealed the presence of an IgM kappa monoclonal spike, suggesting MGUS. In 2022, the patient was diagnosed with NSCLC harboring the KRAS G12C mutation and initiated second-line treatment with sotorasib. Notably, one year after the initiation of sotorasib therapy, the patient\u2019s hemostasis had normalized, accompanied by significant improvements in VWF levels. VWF multimer electrophoresis demonstrated the restoration of high-molecular-weight multimers (HMWMs), and serum protein electrophoresis no longer detected MGUS. Conclusion: These improvements were likely attributable to the indirect effects of sotorasib on the bone marrow microenvironment. By inhibiting KRAS in stromal cells and osteoclasts, sotorasib may have disrupted the supportive niche necessary for malignant plasma cell survival, resulting in a reduction in the monoclonal spike. Unfortunately, the patient eventually succumbed to carcinogenic pleurisy.<\/jats:p>","DOI":"10.3390\/hematolrep17020021","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:48:46Z","timestamp":1744850926000},"page":"21","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful Management of Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance After Sotorasib Treatment in a Patient with Non-Small-Cell Lung Carcinoma"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6373-7928","authenticated-orcid":false,"given":"M\u00e9lissa","family":"Julien","sequence":"first","affiliation":[{"name":"Centre de Ressources et Comp\u00e9tences des Maladies H\u00e9morragiques Constitutionnelles, H\u00f4pitaux Universitaires de Strasbourg, 67 091 Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Pierre","sequence":"additional","affiliation":[{"name":"Centre de Ressources et Comp\u00e9tences des Maladies H\u00e9morragiques Constitutionnelles, H\u00f4pitaux Universitaires de Strasbourg, 67 091 Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-C\u00e9cile","family":"G\u00e9rout","sequence":"additional","affiliation":[{"name":"Service de Pharmacie, H\u00f4pitaux Universitaires de Strasbourg, 67 091 Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2702-6246","authenticated-orcid":false,"given":"Laurent","family":"Sattler","sequence":"additional","affiliation":[{"name":"Laboratoire D\u2019h\u00e9matologie, H\u00f4pitaux Universitaires de Strasbourg, 67 091 Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Feugeas","sequence":"additional","affiliation":[{"name":"Centre de Ressources et Comp\u00e9tences des Maladies H\u00e9morragiques Constitutionnelles, H\u00f4pitaux Universitaires de Strasbourg, 67 091 Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Desprez","sequence":"additional","affiliation":[{"name":"Centre de Ressources et Comp\u00e9tences des Maladies H\u00e9morragiques Constitutionnelles, H\u00f4pitaux Universitaires de Strasbourg, 67 091 Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00508-022-02012-3","article-title":"Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy: Breaking adangerous bond","volume":"134","author":"Jeryczynski","year":"2022","journal-title":"Wien. Klin. Wochenschr. Juin"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: Focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/jth.15810","article-title":"Von Willebrand factor and cancer: Another piece of the puzzle","volume":"20","author":"Denis","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0037-1619606","article-title":"Acquired von Willebrand syndrome 2004: International Registry\u2014Diagnosis and management from online to bedside","volume":"24","author":"Federici","year":"2004","journal-title":"Hamostaseologie"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2516.1999.00340.x","article-title":"Acquired von Willebrand syndrome\u2014Report of 10 cases and review of the literature","volume":"5","year":"1999","journal-title":"Haemophilia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11239-023-02799-6","article-title":"Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: Long-term remission after treatment with bortezomib","volume":"55","author":"Saldanha","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Chigrinova, E.R., Porret, N.A., Andres, M., Wiedemann, G., Banz, Y., Legros, M., Pollak, M., Oppliger Leibundgut, E., Pabst, T., and Bacher, U. (2022). Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias. BMC Med. Genomics, 15.","DOI":"10.21203\/rs.3.rs-1003362\/v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","article-title":"Targeting the MAPK Pathway in KRAS-Driven Tumors","volume":"37","author":"Drosten","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hon.3208","article-title":"Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma","volume":"41","author":"Perroud","year":"2023","journal-title":"Hematol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e1500","DOI":"10.1002\/ctm2.1500","article-title":"The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K\/AKT\/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis-generating study","volume":"13","author":"Huang","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e3658","DOI":"10.1002\/jgm.3658","article-title":"Single-cell RNA sequencing reveals the mechanism of PI3K\/AKT\/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation","volume":"26","author":"Xu","year":"2024","journal-title":"J. Gene Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1002\/ijc.32624","article-title":"JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression","volume":"145","author":"Mohrherr","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1158\/1541-7786.MCR-20-0275","article-title":"Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice","volume":"19","author":"Osswald","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-024-02218-1","article-title":"The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy","volume":"24","author":"Ma","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1200\/JCO.2009.22.0392","article-title":"Spontaneous Remission in a Patient with t(4;14) Translocation Multiple Myeloma","volume":"27","author":"Puig","year":"2009","journal-title":"J. Clin. Oncol."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/17\/2\/21\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:16:00Z","timestamp":1760030160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/17\/2\/21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["hematolrep17020021"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep17020021","relation":{},"ISSN":["2038-8330"],"issn-type":[{"type":"electronic","value":"2038-8330"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}